Canada markets closed

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed Price. Currency in NOK
Add to watchlist
1.6500-0.0300 (-1.79%)
At close: 04:11PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
19,052
44,756
71,707
75,571
Selling General and Administrative
14,450
16,441
20,595
13,917
Total Operating Expenses
30,710
56,447
86,029
82,120
Operating Income or Loss
-30,710
-56,447
-86,029
-82,120
Interest Expense
-632
127
89
397
Income Before Tax
-29,197
-55,095
-88,391
-72,239
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-29,197
-55,095
-88,391
-72,239
Net Income
-29,197
-55,095
-88,391
-72,239
Net Income available to common shareholders
-29,197
-55,095
-88,391
-72,239
Basic EPS
-0.79
-1.48
-2.37
-1.94
Diluted EPS
-0.79
-1.48
-2.37
-1.94
Basic Average Shares
37,326
37,326
37,326
37,285
Diluted Average Shares
37,326
37,326
37,326
37,285